39KP, you outlined 3 scenario's (copied below), which if you equal weight, says they can't get this trial to the finish line. I can tell you now that I WANT this molecule to be available to the masses, but I do not think it will happen under the umbrella of the current management of this company. I want to be wrong! Can you please for the love of god, implore upon Mr Rennie, that if he truly does have a partnership deal in hand, that relies on an equity stake, to lay it all out to his loyal (suffering) shareholders, who will back it to the cows come home, if they can see funding that completes P3. Right now, the way it is presented, says we can raise another quarter to "bridge" us until who the f$%k knows what...
Only 1 of your scenarios can see this through to the end, but to ask shareholders at this stage of the game to "trust me I've got you covered", I think is a bit of a stretch. Both you and @Huts7 seem to have his ear, or at least access, please give it a try, there is no downside.
Cheers, TR
To my mind there are only 3 potential scenarios - - they have no idea what they are doing - they are lining up for a CR which will hurt - funding is done and the funding partner is taking equity as a pre requisite for the deal and they need to do this first.
PAR Price at posting:
28.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)